The invention to the delta-crystalline form of the compound having formula (I), characterised by its powder X-ray diffraction pattern. The invention also relates to drugs containing same.Forme cristalline delta du composé de formule (I) :caractérisée par son diagramme de diffraction X sur poudre. Médicaments.